Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS
Clinical trial NCT03802799 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03802799
- Sponsor
- Zynerba Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-09
- Primary completion
- 2026-06-30
- Enrollment
- 476
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.